MeSH term | MeSH ID | Detail |
---|---|---|
Amnesia | D000647 | 12 associated lipids |
Hypothermia | D007035 | 19 associated lipids |
Catalepsy | D002375 | 30 associated lipids |
Hypertension | D006973 | 115 associated lipids |
Edema | D004487 | 152 associated lipids |
Elaidamide is a lipid of Fatty Acyls (FA) class. Elaidamide is associated with abnormalities such as Wiskott-Aldrich Syndrome. The involved functions are known as inhibitors, salivary gland development and branching morphogenesis.
To understand associated biological information of Elaidamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Elaidamide is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Elaidamide
MeSH term | MeSH ID | Detail |
---|---|---|
Amnesia | D000647 | 12 associated lipids |
Hypothermia | D007035 | 19 associated lipids |
Catalepsy | D002375 | 30 associated lipids |
Hypertension | D006973 | 115 associated lipids |
Edema | D004487 | 152 associated lipids |
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Boger DL et al. | Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: a probe of structural and conformational features contributing to inhibition. | 1999 | Bioorg. Med. Chem. Lett. | pmid:10021942 |
Cheer JF et al. | Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors. | 1999 | Neuropharmacology | pmid:10221757 |
Jenkins TC | Fatty acid composition of milk from Holstein cows fed oleamide or canola oil. | 1998 | J. Dairy Sci. | pmid:9565883 |
Boger DL et al. | Structural requirements for 5-HT2A and 5-HT1A serotonin receptor potentiation by the biologically active lipid oleamide. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9539697 |
Boger DL et al. | Chemical requirements for inhibition of gap junction communication by the biologically active lipid oleamide. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9560184 |
Huang GY et al. | Gap junction-mediated cell-cell communication modulates mouse neural crest migration. | 1998 | J. Cell Biol. | pmid:9852163 |
Bisogno T et al. | Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation. | 1998 | Eur. J. Biochem. | pmid:9688276 |
Lees G et al. | Modulation of GABA(A) receptors and inhibitory synaptic currents by the endogenous CNS sleep regulator cis-9,10-octadecenoamide (cOA). | 1998 | Br. J. Pharmacol. | pmid:9692771 |
Yost CS et al. | Oleamide potentiates benzodiazepine-sensitive gamma-aminobutyric acid receptor activity but does not alter minimum alveolar anesthetic concentration. | 1998 | Anesth. Analg. | pmid:9620523 |
Thomas EA et al. | Oleamide-induced modulation of 5-hydroxytryptamine receptor-mediated signaling. | 1998 | Ann. N. Y. Acad. Sci. | pmid:9928256 |